Homecare Medicines Services for Immunoglobulin Therapies
Introduction
The Homecare Medicines Services for Immunoglobulin Therapies framework, managed by the East of England NHS, serves as a structured procurement route designed specifically for the acquisition of immunoglobulin therapies. This framework is not a Dynamic Purchasing System (DPS) but operates under a framework agreement, running until the 31st of July, 2024. It facilitates the efficient procurement and delivery of homecare medicines for immunoglobulin therapies, primarily aiding NHS organisations and other publicly funded bodies within the East of England, South East Coast, and Thames Valley and Wessex areas.
Context & Use Case
This framework is essential for healthcare organisations aiming to streamline the procurement of immunoglobulin therapies. The framework operates on a hub and spoke model, where specialist centres are responsible for prescribing treatments, while the framework manages the purchasing and logistics. By centralising the procurement process, the framework enhances the efficiency and effectiveness of delivering these critical therapies. This approach not only ensures timely delivery of medications to patients but also fosters a collaborative purchasing strategy that maximises resource utilisation and cost-effectiveness for participating organisations.
Scope of Services
The framework covers a comprehensive range of services designed to support homecare for patients requiring immunoglobulin therapies. The services typically include: 1. The procurement and supply of immunoglobulin therapies tailored to patient needs. 2. Coordination of home delivery services to ensure timely and efficient distribution of medications. 3. Provision of patient support services, including education and guidance on therapy administration. 4. Monitoring and reporting on service delivery and patient outcomes to ensure quality and compliance.
Who Can Apply
The framework is primarily open to suppliers who specialise in the provision of immunoglobulin therapies and related homecare services. It is suitable for pharmaceutical companies, logistics providers specialising in medical deliveries, and organisations offering patient support services. As this is not a DPS, applications are typically only open during specific tendering periods, so interested suppliers should stay informed about any opportunities to apply.
Buyer Benefits
Public sector buyers benefit significantly from using this framework. It ensures compliance with public procurement regulations, providing a transparent and competitive purchasing environment. By leveraging collective buying power, the framework offers participating organisations access to improved pricing and service levels. Additionally, the streamlined procurement process reduces administrative burdens, allowing healthcare providers to focus more on patient care rather than logistical concerns.
Lots
Not applicable
Next Steps
Suppliers interested in participating in this framework should thoroughly review the framework requirements and eligibility criteria. It is advisable to contact the East of England NHS directly to obtain detailed information and guidance on the application process, ensuring all necessary documentation and qualifications are in order.
How Biddable Can Help
Biddable offers support to suppliers by providing comprehensive insights into available frameworks, such as the Homecare Medicines Services for Immunoglobulin Therapies framework. Our services facilitate the discovery of suitable opportunities, preparation for applications, and ongoing visibility into procurement pipelines. We aim to assist suppliers in navigating the complexities of public sector procurement, helping them to make informed decisions about their participation in relevant frameworks.